Shining the spotlight on cardioprotection: beyond the cardiomyocyte

Cardiovasc Res. 2019 Jun 1;115(7):1115-1116. doi: 10.1093/cvr/cvz072.

Sean M Davidson¹, Ioanna Andreadou², David Garcia-Dorado^{3

4}, Derek J Hausenloy^{5

6

7

8

9

10}

¹ The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, UK.
² Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
³ Department of Cardiology, Vascular Biology and Metabolism Area, Vall d'Hebron University Hospital and Research Institute (VHIR), Universitat Autónoma de Barcelona, Spain.
⁴ Instituto CIBER de Enfermedades Cardiovasculares (CIBERCV): Instituto de Salud Carlos III, Madrid, Spain.
⁵ Cardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore.
⁶ National Heart Research Institute Singapore, National Heart Centre, Singapore.
⁷ Yong Loo Lin School of Medicine, National University Singapore, Singapore.
⁸ The Hatter Cardiovascular Institute, University College London, London, UK.
⁹ The National Institute of Health Research University College London Hospitals Biomedical Research Centre, Research & Development, London, UK.
¹⁰ Tecnologico de Monterrey, Centro de Biotecnologia-FEMSA, Nuevo Leon, Mexico.

No abstract available

Publication types